Scott Rodig

Dr. Rodig is an anatomic and molecular pathologist at Brigham & Women’s Hospital, Director of the Hematopathology Fellowship at Brigham & Women's Hospital, Director of the Tissue Biomarker Laboratory of the Center for Immuno-Oncology at the Dana-Farber Cancer Institute, and an Associate Professor of Pathology at Harvard Medical School. Dr. Rodig’s laboratory focuses on the development and application of novel tissue-based biomarker assays to improve the diagnosis of and to guide therapy for human cancer. Techniques his group employ include targeted genetic testing with customized fluorescence in-situ hybridization (FISH) probes, targeted gene expression profiling, and multiplex immunofluorescence staining coupled with digital image analysis. His group has discovered and characterized disease mechanisms underlying Hodgkin lymphoma, diffuse large B-cell lymphoma, specialized forms of lung cancer, and melanoma that have resulted in new diagnostic tests to direct clinical trial enrollment and personalized therapy.

Clinical Interests

• Pathology

Education

Medical School

• Washington University School of Medicine

Residency

• Brigham and Women's Hospital, 1998 - 2002

Board Certifications

• Anatomic Pathology, 2002
• Hematopathology, 2002
• Pathology Recertification, 2014